In the auditorium of the American Association for the Advancement of Technology , 1200 NY Avenue, N.W., in Washington, D.C. A reception will precede the program at 5 p.m. Please note that press must RSVP. Co-sponsored by AAAS and the Georgetown University Program on Science in the general public Interest, another two occasions in the Science & Society series will include the next presenters and topics: Nov. 1: Topic: Coming to the Table on Meals Security Professionals: Sarah Vogel, Johnson Family Foundation Christopher Borgert, University of Florida, GainesvilleHost: Jon Hamilton, National Open public Radio Nov.Tim Fischell, CEO and CMO of ASI.’ Related StoriesDiabetic retinopathy therapy improvements: an interview with Richard Kirk, CEO of PolyphotonixJumping genes: a marker for early tumor medical diagnosis? An interview with Dr KazazianMelatonin and the circadian rhythm: an interview with Professor Kennaway, University of Adelaide’We think that ASI’s simple, elegant strategy will effectively address the clinical need,’ mentioned Dr. Vartan Ghazarossian, President and COO of ASI. Steven Almany of BioStar Ventures, an associate of ASI’s Board of Directors, commented: ‘The therapeutic potential of perivascular renal denervation is very attractive, and we have become pleased to spend money on ASI’s team because they develop their particular approach.